Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company. Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd.
The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours. The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical ... products and is governed by a number of central and state legislations that regulate the business. Apart from the bulk drug manufacturing activity, they also undertake importing & distributing of various industrial chemicals & solvents throughout the country. The company has their manufacturing unit located at Thane.
The company's products include Methyl Nitro Imidazole, Metronidazole & Metronidazole Benzoate. Their pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. The pharmaceutical products offered by the company are in compliance with IP/ BP/ CP/ USP standards. They have their registered office is located at Thane and their corporate office is located at Mumbai.
The company was established with the main object setting up manufacturing facilities for Bulk Drugs. In the year 1993, the company came with a public issue of 27,50,000 equity shares of Rs 10 each for cash at par aggregating to Rs 275 lakh. Also, the company shares were listed on the BSE, ASE & DSE.
In May 2009, the company plant started to upgrade the existing plant into international standards.
In June 2016, the Company commenced manufacturing of Mono Methyl Urea & Di Methyl Urea. In 2017-18, it added new products i.e. Erithromycin Derivates & Mafenamic Acid with capacity of 10 m.t. & 25 m.t. respectively in June' 2017.
In 2018-19, it commenced manufacturing of products i.e. Ortho Para Nitro Anisole, 2-Bromomethyl-1,3 dioxolane, and Mefenamic Acid. It also commenced manufacturing products i.e.Metformin & Urasil.
1. Can I buy Aarey Drugs & Pharmaceuticals Ltd from PL Capital? ›
Yes, you can invest in Aarey Drugs & Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Aarey Drugs & Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Aarey Drugs & Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Aarey Drugs & Pharmaceuticals Ltd pay dividends? ›
Aarey Drugs & Pharmaceuticals Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Aarey Drugs & Pharmaceuticals Ltd ? ›
As of
16-01-2026 the share price for Aarey Drugs & Pharmaceuticals Ltd. is 64.17 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Aarey Drugs & Pharmaceuticals Ltd ? ›
The 52-week high and low of Aarey Drugs & Pharmaceuticals Ltd share price is ₹ 31.35 - ₹ 100 as of
16-01-2026 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
